US group questions human embryo research, calls for rules
By DPA,
Deutsche Presse-Agentur [cites Marcy Darnovsky]
| 05. 14. 2008
A US public interest group has called for the US to set up national bioethics standards and regulations on embryonic research after a group of scientists in New York State produced a genetically-engineered embryo, dpa reported.
The Center for Genetics and Society, located in Oakland, California, said Tuesday the need for such standards was clear after the research at Cornell University was brought to light by a London newspaper over the weekend. Britain is in the process of revamping its genetic research laws.
Marcy Darnovsky of the Center for Genetics and Society told Deutsche Presse-Agentur dpa that the US urgently needs federal bioethical standards and a regulatory panel similar to those in Canada and Britain or even Germany, which has some of the most stringent rules on genetic research.
"The prospect of genetic technology being used to introduce new types of genetic inequality and social division, to create genetically-enhanced children is the core of our concern," Darnovsky said.
A brief account of the study by scientists at Cornell University was published in September 2007 in the journal Fertility and Sterility...
Related Articles
By Fyodor D. Urnov and Sadik H. Kassim, Nature | 04.21.2026
In February, the US Food and Drug Administration (FDA) proposed a radical rethink of how scientists, physicians and manufacturers develop personalized genetic therapies. The regulator’s suggested introduction of a ‘plausible mechanism pathway’ should increase incentives for drug companies to develop...
By Miguel Muñoz, Cadena SER | 08.04.2026
"Para ellos, una familia numerosa no solo es una preferencia personal, sino que es una obligación. Creen que tener tantos hijos como sea posible es necesario para evitar un futuro apocalíptico", aseguraba Xavier Orri, periodista y cofundador de Página Internacional...
By Ryan Knutson and Jessica Mendoza, The Journal. | 03.27.2026
Genetically engineered babies are banned in the U.S. But that isn’t stopping Silicon Valley tech titans from trying to make one. In this final installment from The Journal’s investigation into the fringes of the fertility industry, WSJ’s Emily Glazer reports...
By Antonio Regalado, MIT Technology Review | 03.30.2026
After operating in secrecy for years, a startup company called R3 Bio, in Richmond, California, suddenly shared details about its work last week—saying it had raised money to create nonsentient monkey “organ sacks” as an alternative to animal testing.
In...
